Preliminary reports suggest conolidine may perhaps inhibit particular ion channels, cutting down neuronal excitability and limiting discomfort indicators. This system is particularly suitable in neuropathic suffering, wherever abnormal signaling results in persistent pain. Also, conolidine seems to affect G protein-coupled receptor (GPCR) pathways